secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTENSITY THERAPEUTICS, INC. (INTS)
CIK:        0001567264
Form:       8-K
Filed at:   2025-06-06T23:59:59+00:00
Accession:  0001567264-25-000056
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Intensity Therapeutics receives Nasdaq minimum bid price deficiency notice
--------------------------------------------------------------------------

- Nasdaq notified INTS on June 6, 2025 that bid price was below $1.00 for 30 consecutive business days.
- Company has a 180-day grace period, until December 3, 2025, to regain compliance.
- Compliance can be achieved if closing bid price is $1.00 or more for 10 consecutive business days.
- If not compliant by deadline, INTS may seek a second grace period or consider a reverse stock split.
- No immediate effect on listing or trading; stock continues on Nasdaq Capital Market under symbol INTS.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000056/0001567264-25-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1567264/000156726425000056/intensity-20250606.htm
  HTML page:      https://secwatch.observer/filing/0001567264-25-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer